Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Acetic acid, glacial 💬1件: Acetic acid2件: Acetic acid; Ethanoate--3件: 97, 251, 296 💬
2 Albumin human 💬1件: Albumin human3件: Albumin; Human albumin; Serum albumin--5件: 2, 11, 50, 222, 296 💬
3 Ammonia solution, strong 💬1件: Ammonia1件: Ammonia--3件: 88, 251, 296 💬
4 Belimumab 💬1件: Belimumab1件: Belimumab1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
5 Bezafibrate 💬1件: Bezafibrate1件: Bezafibrate1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
6 Cefoperazone 💬1件: Cefoperazone1件: Cefoperazone--1件: 296 💬
7 Cefoperazone sodium 💬1件: Cefoperazone1件: Cefoperazone--1件: 296 💬
8 Desflurane 💬1件: Desflurane1件: Desflurane--2件: 22, 296 💬
9 Dexamethasone 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
10 Dexamethasone phosphate 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
11 Dexamethasone sodium phosphate 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
12 Dimethyl fumarate 💬1件: Dimethyl fumarate2件: Dimethyl fumarate; Dimethylfumarat1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬6件: 13, 20, 49, 51, 86, 296 💬
13 Donkey glue 💬1件: Gelatin2件: Gelatin; Gelatine--5件: 19, 47, 62, 70, 296 💬
14 Filgrastim 💬1件: Filgrastim3件: Filgrastim; G-CSF; Granulocyte colony stimulating factor1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬29件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
15 Folate sodium 💬1件: Folic acid4件: Acide folique; Folacin; Folate; Folic acid--7件: 41, 46, 84, 96, 97, 172, 296 💬
16 Folic acid 💬1件: Folic acid4件: Acide folique; Folacin; Folate; Folic acid--7件: 41, 46, 84, 96, 97, 172, 296 💬
17 Gelatin 💬1件: Gelatin2件: Gelatin; Gelatine--5件: 19, 47, 62, 70, 296 💬
18 Human serum albumin 💬1件: Albumin human3件: Albumin; Human albumin; Serum albumin--5件: 2, 11, 50, 222, 296 💬
19 Icosapent 💬1件: Icosapent1件: Eicosapentaenoic acid--6件: 49, 96, 97, 296, 297, 338 💬
20 Indocyanine green 💬1件: Indocyanine green1件: Indocyanine green--8件: 22, 46, 51, 96, 235, 278, 291, 296 💬
21 Lactobacillus casei 💬1件: Lactobacillus casei1件: Lactobacillus casei--3件: 6, 97, 296 💬
22 Magnesium gluconate 💬1件: Magnesium gluconate1件: Magnesium gluconate--2件: 296, 297 💬
23 Magnesium sulfate 💬1件: Magnesium sulfate2件: Magnesium sulfate; Magnesium sulfate heptahydrate--4件: 11, 97, 296, 297 💬
24 Maralixibat 💬1件: Maralixibat2件: Maralixibat; Maralixibat chloride2件: SLC10A1,
SLC10A2 💬
3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬4件: 296, 297, 299, 338 💬
25 Maralixibat chloride 💬1件: Maralixibat2件: Maralixibat; Maralixibat chloride1件: SLC10A2 💬 1件: Bile secretion 💬4件: 296, 297, 299, 338 💬
26 Meloxicam 💬1件: Meloxicam1件: Meloxicam1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬3件: 46, 271, 296 💬
27 Methylprednisolone 💬1件: Methylprednisolone3件: Methylprednisolon; Methylprednisolone; Methylprednisolone acetate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
28 Methylprednisolone acetate 💬1件: Methylprednisolone3件: Methylprednisolon; Methylprednisolone; Methylprednisolone acetate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
29 Neomycin 💬1件: Neomycin1件: Neomycin--3件: 96, 97, 296 💬
30 Neomycin palmitate 💬1件: Neomycin1件: Neomycin--3件: 96, 97, 296 💬
31 Neomycin sulfate 💬1件: Neomycin1件: Neomycin--3件: 96, 97, 296 💬
32 Noradrenaline 💬1件: Norepinephrine2件: Norepinephrine; Norepinephrine bitartrate9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296 💬
33 Norepinephrine bitartrate 💬1件: Norepinephrine2件: Norepinephrine; Norepinephrine bitartrate9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296 💬
34 Norepinephrine hydrochoride 💬1件: Norepinephrine2件: Norepinephrine; Norepinephrine bitartrate9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296 💬
35 Obeticholic acid 💬1件: Obeticholic acid2件: 6-ecdca; Obeticholic acid1件: NR1H4 💬 1件: Bile secretion 💬3件: 93, 265, 296 💬
36 Odevixibat 💬1件: Odevixibat1件: Odevixibat1件: SLC10A2 💬 1件: Bile secretion 💬3件: 296, 297, 338 💬
37 Pentoxifylline 💬1件: Pentoxifylline1件: Pentoxifylline--11件: 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
38 Prednisolone 💬1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬39件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
39 Propofol 💬1件: Propofol1件: Propofol16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
40 Propranolol 💬1件: Propranolol3件: Propanolol; Propranolol; Propranolol hydrochloride3件: ADRB1,
ADRB2,
ADRB3 💬
14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 158, 215, 216, 278, 296 💬
41 Propranolol hydrochloride 💬1件: Propranolol3件: Propanolol; Propranolol; Propranolol hydrochloride3件: ADRB1,
ADRB2,
ADRB3 💬
14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 158, 215, 216, 278, 296 💬
42 Rifaximin 💬1件: Rifaximin2件: Rifaximin; Rifaximina--8件: 6, 65, 93, 96, 97, 99, 296, 299 💬
43 Rituximab 💬1件: Rituximab1件: Rituximab1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
44 Rocuronium bromide 💬1件: Rocuronium2件: Rocuronium; Rocuronium bromide16件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB2,
CHRNB3,
CHRNB4 💬
16件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 70, 296 💬
45 Sevoflurane 💬1件: Sevoflurane1件: Sevoflurane--8件: 6, 21, 22, 34, 70, 98, 225, 296 💬
46 Ursodiol 💬1件: Ursodeoxycholic acid3件: Udca; Ursodeoxycholic acid; Ursodiol1件: NR1H4 💬 1件: Bile secretion 💬13件: 6, 8, 20, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬
47 Vancomycin 💬1件: Vancomycin1件: Vancomycin--8件: 13, 46, 70, 94, 96, 97, 296, 299 💬
48 Vancomycin hydrochloride 💬1件: Vancomycin1件: Vancomycin--8件: 13, 46, 70, 94, 96, 97, 296, 299 💬